Carolina Eye Associates participates in clinical research studies, often referred to clinical trials. Clinical trials allow for the scientific testing necessary to develop new and improved drugs and therapies. These studies are tightly regulated and most are controlled by the U.S. Food and Drug Administration.
In a clinical trial, new drugs and therapies are tested in a scientific way. In some trials, half of the patients receive an experimental therapy and the other half receives a placebo (a harmless pill or medicine that has no therapeutic effect). During this type of trial, neither the patient nor the doctor knows which therapy the patient has received. This is done to eliminate bias and subjectivity in the results.
Because most clinical trials require very specific clinical findings to be present in study patients, some patients are not eligible to participate in the trials. If you want more information about these trials, please contact our clinical trials coordinator by calling (910) 255-2053 or toll-free at (800) 733-5357 ext. 881. Our coordinator can give you additional information about the inclusion and exclusion criteria for each study.
Clinical trials currently open:
- Seeking patients in a two-year, randomized, double-masked, multicenter, three-arm study comparing the efficacy and safety of RTH258 versus aflibercept in subjects with neovascular age-related macular degeneration.